2018 ESC/ESH Guidelines for the management of arterial hypertension

Williams, Bryan, Mancia, Giuseppe, Spiering, Wilko, Agabiti Rosei, Enrico, Azizi, Michel, Burnier, Michel, Clement, Denis L, Coca, Antonio +203 more·2018·European Heart Journal

Cited by (1,025)

Items 701–800 of 1,025

  1. Blood pressure targets for the treatment of people with hypertension and cardiovascular disease
    Luis Carlos Saiz, Javier Gorricho, Javier Garjón, Ma Concepción Celaya, Juan Erviti, Leire Leache · 2022 · Cochrane Database of Systematic Reviews
  2. Non-Dipping Blood Pressure or Nocturnal Hypertension: Does One Matter More?
    Amber B. Tang, Eugene Yang, Joseph E. Ebinger · 2023 · Current Hypertension Reports
  3. Insulin resistance assessed by estimated glucose disposal rate and risk of atherosclerotic cardiovascular diseases incidence: the multi-ethnic study of atherosclerosis
    Jiayi Yi, Chao Qu, Xiang Li, Hai Gao · 2024 · Cardiovascular Diabetology
  4. Plasma copper and the risk of first stroke in hypertensive patients: a nested case-control study
    Jingping Zhang, Jingjing Cao, Hao Zhang, Chongfei Jiang, Teng-Fei Lin, Ziyi Zhou, Yun Song, Youbao Li, Chengzhang Liu, Lishun Liu et al. · 2019 · American Journal of Clinical Nutrition
  5. Emergence of digital biomarkers to predict and modify treatment efficacy: machine learning study
    Nicole L Guthrie, Jason Carpenter, Katherine L Edwards, Kevin J Appelbaum, Sourav Dey, David M. Eisenberg, David L. Katz, Mark A Berman · 2019 · BMJ Open
  6. Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan
    Tran Thi Khanh Tuong, Tran Dang Khoa, Pham Quang Thien Phu, Tong Nguyen Diem Hong, Thien Chu Dinh, Dinh‐Toi Chu · 2020 · Diagnostics
  7. Systolic Blood Pressure and Longitudinal Progression of Arterial Stiffness: A Quantitative Meta‐Analysis
    J F Wilson, Alastair J.S. Webb · 2020 · Journal of the American Heart Association
  8. Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus
    Suriya Prausmüller, Michael Resl, Henrike Arfsten, Georg Spinka, Raphael Wurm, Stephanie Neuhold, Philipp Emanuel Bartko, Georg Goliasch, Guido Strunk, Noémi Pávó et al. · 2021 · Cardiovascular Diabetology
  9. Difference between morning and evening home blood pressure and cardiovascular events: the J-HOP Study (Japan Morning Surge-Home Blood Pressure)
    Keisuke Narita, Satoshi Hoshide, Kazuomi Kario · 2021 · Hypertension Research
  10. Primary prevention of cardiovascular disease: Updated review of contemporary guidance and literature
    Jack Stewart, Katherine Addy, Sarah Campbell, Peter Wilkinson · 2020 · JRSM Cardiovascular Disease
  11. Indexing Left Atrial Volumes
    Esther Davis, Daniela R. Crousillat, Wei Wu He, Carl T. Andrews, Judy Hung, Jacqueline Suk Danik · 2022 · JACC. Cardiovascular imaging
  12. Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus: The ADVANCE Trial
    Rahman, Faisal, McEvoy, John W., Ohkuma, Toshiaki, Marre, Michel, Hamet, Pavel, Harrap, Stephen, Mancia, Giuseppe, Rodgers, Anthony, Selvin, Elizabeth, Williams, Bryan et al. · 2019 · Hypertension
  13. Associations of genetic susceptibility and healthy lifestyle with incidence of coronary heart disease and stroke in individuals with hypertension
    Mengyao Wang, Søren Brage, Stephen J. Sharp, Shan Luo, Shiu Lun Au Yeung, Youngwon Kim · 2022 · European Journal of Preventive Cardiology
  14. Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round Table
    Francesco Cosentino, Subodh Verma, Phil Ambery, Marianne Bach Treppendahl, Martin van Eickels, Stefan D. Anker, Michele Cecchini, Paola Fioretto, Per‐Henrik Groop, David A. Hess et al. · 2023 · European Heart Journal
  15. Update on the Use of Pulse Wave Velocity to Measure Age-Related Vascular Changes
    Andrea Gail Marshall, Kit Neikirk, Jeremiah Afolabi, Naome Mwesigwa, Bryanna Shao, Annet Kirabo, Anilkumar K. Reddy, Antentor Othrell Hinton Jr. · 2023 · Current Hypertension Reports
  16. Evaluation and management of hypertensive emergency
    Joseph B Miller, Daniel Hrabec, Vijay Krishnamoorthy, Harish A. Kinni, Robert D. Brook · 2024 · BMJ
  17. Eplerenone Versus Spironolactone in Resistant Hypertension: an Efficacy and/or Cost or Just a Men’s Issue?
    Antonis S. Manolis, Theodora A. Manolis, Helen Melita, Antonis S. Manolis · 2019 · Current Hypertension Reports
  18. Declined circulating Elabela levels in patients with essential hypertension and its association with impaired vascular function: A preliminary study
    Yutao Li, Xulong Yang, Shun Ouyang, Jiang He, Bingbo Yu, Xiufang Lin, Qunying Zhang, Jun Tao · 2019 · Clinical and Experimental Hypertension
  19. Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management
    Susanne Saußele, Wilhelm Haverkamp, Fabian Lang, Steffen Koschmieder, Alexander Kiani, Kathleen Jentsch‐Ullrich, Frank Stegelmann, Heike Pfeifer, Paul Graf La Rosée, Nicola Goekbuget et al. · 2019 · Acta Haematologica
  20. Diastolic Blood Pressure and Heart Rate Are Independently Associated With Mortality in Chronic Aortic Regurgitation
    Li‐Tan Yang, Patricia A. Pellikka, Maurice L. Enriquez-Sarano, Christopher G. Scott, Ratnasari Padang, Sunil V. Mankad, Hartzell Vernon Schaff, Héctor I. Michelena · 2020 · Journal of the American College of Cardiology
  21. Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two–Lipid Center Real-World Experience
    Giuseppe Mandraffino, Roberto Scicali, Javier Rodríguez‐Carrio, Francesca Savarino, Federica Mamone, Michele Scuruchi, Maria Cinquegrani, Egidio Imbalzano, Antonino Di Pino, Salvatore Piro et al. · 2020 · Journal of clinical lipidology
  22. Type 2 diabetes and prediabetes prevalence in patients with different risk factor combinations in the NATION study
    Ekaterina Alekseevna Shestakova, E. Yu. Lunina, Gagik Radikovich Galstyan, Marina Vladimirovna Shestakova, Ivan Ivanovich Dedov · 2020 · Diabetes Mellitus
  23. COVID‐19 and renin‐angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) ‐ Is there any scientific evidence for controversy?
    Aneta Aleksova, Federico Ferro, Giulia Gagno, Chiara Cappelletto, Daniela Santon, Maddalena Rossi, Giuseppe Ippolito, Alimuddin I. Zumla, Antonio Paolo Beltrami, Gianfranco Sinagra · 2020 · Journal of Internal Medicine
  24. Blood pressure control in type 2 diabetes mellitus with arterial hypertension. The important ancillary role of SGLT2-inhibitors and GLP1-receptor agonists
    Cesare Berra, Roberto Manfrini, Damiano Regazzoli, Maria Grazia Radaelli, Olga Disoteo, Carmen Sommese, Paolo Fiorina, Giuseppe Ambrosio, Franco B. Folli · 2020 · Pharmacological Research
  25. Frailty and hypertension in older adults: current understanding and future perspectives
    Pan Liu, Yun Li, Yaxin Zhang, Seyed Erfan Mesbah, Tong Ji, Lina Ma · 2020 · Hypertension Research
  26. White-Coat Hypertension Without Organ Damage: Impact on Long-Term Mortality, New Hypertension, and New Organ Damage
    Giuseppe Mancia, Rita Facchetti, Jennifer Vanoli, Raffaella Dell’Oro, Gino Seravalle, Guido Grassi · 2022 · Hypertension
  27. Left atrial stiffness index as a marker of early target organ damage in hypertension
    Yixiao Zhao, Qiaobing Sun, Jiayu Han, Yan Lu, Ying Zhang, Wei Song, Yunpeng Cheng, Tao Cong, Yan Liu, Yinong Jiang · 2020 · Hypertension Research
  28. Dose-Response Relationship Between Long-Term Blood Pressure Variability and Cognitive Decline
    Chenglong Li, Yanjun Ma, Rong Hua, Zhenchun Yang, Bao‐Liang Zhong, Hongyu Wang, Wuxiang Xie · 2021 · Stroke
  29. The renin–angiotensin system biomolecular cascade: a 2022 update of newer insights and concepts
    Carlos Maria Ferrario, Leanne Groban, Hao Wang, Xuming Sun, Jessica L. VonCannon, Kendra N. Wright, Sarfaraz Ahmad · 2022 · Kidney International Supplements
  30. Long-term effects of weight-reducing diets in people with hypertension
    Thomas Semlitsch, Cornelia Krenn, Klaus Jeitler, Andrea Berghold, Karl Horvath, Andrea Siebenhofer · 2021 · Cochrane Database of Systematic Reviews
  31. Using Machine Learning Techniques to Develop Risk Prediction Models for the Risk of Incident Diabetic Retinopathy Among Patients With Type 2 Diabetes Mellitus: A Cohort Study
    Yuedong Zhao, Xinyu Li, Li Shen, Mengxing Dong, Han Yu, Mengxian Zhang, Weidao Chen, Peihua Li, Qing Yu, Xuhan Liu et al. · 2022 · Frontiers in Endocrinology
  32. Effects of regular sauna bathing in conjunction with exercise on cardiovascular function: a multi-arm, randomized controlled trial
    Earric Lee, Iiris Kolunsarka, Joel Kostensalo, Juha P. Ahtiainen, Eero A. Haapala, Peter Willeit, Setor Kwadzo Kunutsor, Jari Antero Laukkanen · 2022 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  33. Angiotensin Receptor Blockers in the Management of Hypertension: A Real-World Perspective and Current Recommendations
    Giovanna Gallo, Massimo Volpe, Speranza Donatella Rubattu · 2022 · Vascular Health and Risk Management
  34. The role of sex and gender in hypertension
    Zahra Azizi, Pouria Alipour, Valeria Raparelli, Colleen M. Norris, Louise Pilote · 2022 · Journal of Human Hypertension
  35. Stage 1 Hypertension and the 10‐Year and Lifetime Risk of Cardiovascular Disease: A Prospective Real‐World Study
    Xinyi Peng, Cheng Jin, Qirui Song, Shouling Wu, Jun Cai · 2023 · Journal of the American Heart Association
  36. Comparison of the diagnostic performance of twelve noninvasive scores of metabolic dysfunction-associated fatty liver disease
    Haoxuan Zou, Xiaopu Ma, Fan Zhang, Yan Xie · 2023 · Lipids in Health and Disease
  37. Prognostic Implications of the Extent of Cardiac Damage in Patients With Fabry Disease
    Maria Chiara Meucci, Rosa Lillo, Annamaria Del Franco, Emanuele Monda, Giulia Iannaccone, Riccardo Baldassarre, Federico Di Nicola, Vanda Parisi, Antonella Lombardo, Letìzia Spinelli et al. · 2023 · Journal of the American College of Cardiology
  38. Impact of poor medication adherence on clinical outcomes and health resource utilization in patients with hypertension and/or dyslipidemia: systematic review
    André Pascal Kengne, J Brière, Lucía Zhu, Jingya Li, Mandeep Kaur Bhatia, Petar Atanasov, Zeba M. Khan · 2023 · Expert Review of Pharmacoeconomics & Outcomes Research
  39. White Coat Hypertension in Children and Adolescents.
    C. Hanevold · 2019 · HYPERTENSION
  40. A Review of Exercise as Medicine in Cardiovascular Disease: Pathology and Mechanism
    Piotr Gronek, Dariusz Wieliński, Piotr Cygański, Andrzej Rynkiewicz, Adam Zając, Adam Maszczyk, Joanna Gronek, Robert Podstawski, Wojciech Czarny, Štefan Balkó et al. · 2020 · Aging and Disease
  41. Sixteen‐Week Physical Activity Intervention in Subjects With Increased Cardiometabolic Risk Shifts Innate Immune Function Towards a Less Proinflammatory State
    Marlies P. Noz, Yvonne Hartman, Maria T. E. Hopman, Peter H.G.M. Willems, Cees J. Tack, Leo A. B. Joosten, Mihai Gheorghe Netea, Dick H. J. Thijssen, Niels Peter Riksen · 2019 · Journal of the American Heart Association
  42. Progression of arterial stiffness is associated with midlife diastolic blood pressure and transition to late-life hypertensive phenotypes
    Webb, Alastair John Stewart · 2020 · Journal of the American Heart Association
  43. Asian management of hypertension: Current status, home blood pressure, and specific concerns in Taiwan
    Hao‐Min Cheng, Hung‐Ju Lin, Tzung‐Dau Wang, Chen‐Huan Chen · 2019 · Journal of Clinical Hypertension
  44. A Physical Activity Recommender System for Patients With Arterial Hypertension
    Luciano Rodrigo Ferretto, Ericles Andrei Bellei, Daiana Biduski, Luiz Carlos Pereira Bin, Mirella Moura Moro, Cristiano Roberto Cervi, Ana Carolina Bertoletti De Marchi · 2020 · IEEE Access
  45. Patiromer Versus Placebo to Enable Spironolactone Use in Patients with Resistant Hypertension and Chronic Kidney Disease ( AMBER ): Results in the Pre-Specified Subgroup with Heart Failure
    Patrick Rossignol, Bryan Williams, Martha R. Mayo, Suzette Warren, Susan P. Arthur, Gail Ackourey, William B. White, Rajiv Agarwal · 2020 · European Journal of Heart Failure
  46. Carotid‐Femoral Pulse Wave Velocity as a Risk Marker for Development of Complications in Type 1 Diabetes Mellitus
    Ninna Hahn Tougaard, Simone Theilade, Signe Abitz Winther, Nete Tofte, Tarunveer S. Ahluwalia, Tine W. Hansen, Peter R Rossing, Marie Frimodt‐Møller · 2020 · Journal of the American Heart Association
  47. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study
    Edouard L. Fu, Catherine M. Clase, Marie Evans, Bengt Lindholm, Joris I. Rotmans, Friedo Wilhelm Dekker, Merel van Diepen, Juan Jesús Carrero · 2020 · American Journal of Kidney Diseases
  48. Effects of insomnia and restless legs syndrome on sleep arterial blood pressure: A systematic review and meta-analysis
    Giuseppe Maiolino, Valeria Bisogni, Davide Soranna, Martino Francesco Pengo, Giacomo Pucci, Roberto Vettor, Cristiano Fava, GianLuca Colussi, Grzegorz Bilo, Carolina Lombardi et al. · 2021 · Sleep Medicine Reviews
  49. French recommendations for the management of Takayasu’s arteritis
    David Saadoun, Alessandra Bura-Rivière, Cloé Comarmond, M. Lambert, Alban B. Redheuil, Tristan Mirault, Collaborators, Paul Achouh, Florence A. Aeschlimann, Jean-Marc Alsac et al. · 2021 · Orphanet Journal of Rare Diseases
  50. The prevalence and predictors of cardiovascular diseases in Kherameh cohort study: a population-based study on 10,663 people in southern Iran
    Najibullah Baeradeh, Masoumeh Ghoddusi Johari‬, Leila Moftakhar, Ramin Rezaeianzadeh, Seyed Vahid Hosseini, Abbas Rezaianzadeh · 2022 · BMC Cardiovascular Disorders
  51. Russian Society of Cardiology position paper on 2018 Guidelines of the European Society of Cardiology/European Society of Arterial Hypertension for the management of arterial hypertension
    Zhanna D. Kobalava, А. О. Конради, Sergey Vladimirovich Nedogoda, G. P. Arutyunov, Е. И. Баранова, О. Л. Барбараш, Виллевальде Светлана Вадимовна, Albert S. Galyavich, М. Г. Глезер, Oksana M. Drapkina et al. · 2018 · Russian Journal of Cardiology
  52. Characteristics of Cardiac Injury in Critically Ill Patients With Coronavirus Disease 2019
    Denis Doyen, Pierre Dupland, Lucas Morand, Etienne Fourrier, Clément Saccheri, Matthieu Buscot, Hervé Hyvernat, Émile Ferrari, Gilles Bernardin, Alain Cariou et al. · 2020 · CHEST Journal
  53. Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension
    Tetsuro Tsujimoto, Hiroshi Kajio · 2020 · Journal of the American Heart Association
  54. European Society of Cardiology Quality Indicators for Cardiovascular Disease Prevention: developed by the Working Group for Cardiovascular Disease Prevention Quality Indicators in collaboration with the European Association for Preventive Cardiology of the European Society of Cardiology
    Suleman Aktaa, Bariş Gencer, Elena Arbelo, Constantinos H. Davos, Ileana Désormais, Monika Hollander, Ana Abreu, Marco Ambrosetti, Maria Bäck, David Carballo et al. · 2021 · European Journal of Preventive Cardiology
  55. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry
    Luís Rocha Lopes, Maria Angela Losi, Nabeel Sheikh, Cécile Laroche, Philippe Charron, Juan Ramón Gimeno, Juan Pablo Kaski, Aldo Pietro Maggioni, Luigi Tavazzi, Eloisa Arbustini et al. · 2022 · European Heart Journal - Quality of Care and Clinical Outcomes
  56. Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation
    Michel Azizi, Felix Mahfoud, Michael A. Weber, Andrew S. P. Sharp, Roland Erich Schmieder, Philipp C. Lurz, Melvin David Lobo, Naomi D.L. Fisher, Joost Daemen, Michael J. Bloch et al. · 2022 · JAMA Cardiology
  57. Development of a Health Behavioral Digital Intervention for Patients With Hypertension Based on an Intelligent Health Promotion System and WeChat: Randomized Controlled Trial
    Ting Sun, Xuejie Xu, Zenghui Ding, Hui Xie, Linlin Ma, Jing Zhang, Yuxin Xia, Guoli Zhang, Zuchang Ma · 2024 · JMIR mhealth and uhealth
  58. Coronary Artery Disease in Adults With Coarctation of Aorta: Incidence, Risk Factors, and Outcomes
    Alexander C. Egbe, Charanjit S. Rihal, Alexa Thomas, Amber N. Boler, Nandini S. Mehra, Kylie J. Andersen, Srikanth Reddy Kothapalli, Nathaniel W. Taggart, Heidi M. Connolly · 2019 · Journal of the American Heart Association
  59. Gender differences in the association between socioeconomic status and hypertension in France: A cross-sectional analysis of the CONSTANCES cohort
    Lola Neufcourt, Séverine Deguen, Sahar Bayat, Marie Zins, Olivier Grimaud · 2020 · PLoS ONE
  60. Management of patients with combined arterial hypertension and aortic valve stenosis: a consensus document from the Council on Hypertension and Council on Valvular Heart Disease of the European Society of Cardiology, the European Association of Cardiovascular Imaging (EACVI), and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
    Costantino Mancusi, Giovanni DE SIMONE, Jana Brguljan Hitij, Isabella Sudano, Felix Mahfoud, Gianfranco Parati, Thomas Kahan, Emanuele Barbato, Luc Piérard, Madalina Garbi et al. · 2020 · European Heart Journal - Cardiovascular Pharmacotherapy
  61. The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Cardiovascular Outcomes and All-Cause Mortality in Type 2 Diabetes
    Ilkun, Olesya L., Greene, Tom, Cheung, Alfred K., Whelton, Paul K., Wei, Guo, Boucher, Robert E., Ambrosius, Walter, Chertow, Glenn M., Beddhu, Srinivasan · 2020 · Diabetes Care
  62. Sodium and Potassium Intake and Cardiovascular Disease in Older People: A Systematic Review
    Carla Gonçalves, Sandra Abreu · 2020 · Nutrients
  63. Disparities Between International Guidelines (AHA/ESC/ESVS/ESVM/SVS) Concerning Lower Extremity Arterial Disease: Consensus of the French Society of Vascular Medicine (SFMV) and the French Society for Vascular and Endovascular Surgery (SCVE)
    Guillaume Mahé, Gudrun Böge, Alessandra Bura-Rivière, Nabil Chakfé, J. Constans, Yann Gouëffic, Philippe Lacroix, Claire Le Hello, Gilles Pernod, Antonia Pérez‐Martin et al. · 2020 · Annals of Vascular Surgery
  64. Management of Chronic Hyperkalemia in Patients With Chronic Kidney Disease: An Old Problem With News Options
    Enrique Morales, Paolo Cravedi, Joaquín Manrique · 2021 · Frontiers in Medicine
  65. Knowledge, attitude and practices of lifestyle modification and associated factors among hypertensive patients on-treatment follow up at Yekatit 12 General Hospital in the largest city of East Africa: A prospective cross-sectional study
    Taye Kebede, Zaid Taddese, Abiot Girma · 2022 · PLoS ONE
  66. Isolated Diastolic Hypertension and Risk of Cardiovascular Disease: Controversies in Hypertension - Pro Side of the Argument
    Yuichiro Yano, Hyeon Chang Kim, Hokyou Lee, Nazar Azahar, Sabrina Ahmed, Kaori Kitaoka, Hidehiro Kaneko, Fujimi Kawai, Atsushi Mizuno, Anthony J. Viera · 2022 · Hypertension
  67. Three-stage intelligent support of clinical decision making for higher trust, validity, and explainability
    Sergey Valerevich Kovalchuk, Georgy Kopanitsa, Ilia Vladislavovich Derevitskii, Georgy A. Matveev, Daria A. Savitskaya · 2022 · Journal of Biomedical Informatics
  68. Risk Factors and Cardiovascular Disease in the Elderly
    Pablo Díez‐Villanueva, César Jiménez-Méndez, Clara Bonanad, Sergio García‐Blas, Jose-Ángel Pérez-Rivera, Gonzalo Allo Miguel, Héctor García‐Pardo, Francesç Formiga, Miguel Camafort, Manuel Martínez‐Sellés et al. · 2022 · Reviews in Cardiovascular Medicine
  69. Optimal implementation of the 2019 ESC/EAS dyslipidaemia guidelines in patients with and without atherosclerotic cardiovascular disease across Europe: a simulation based on the DA VINCI study
    Julia Brandts, Sarah L Bray, Guillermo Villa, Alberico Luigi Catapano, Neil R Poulter, Antonio J. Vallejo‐Vaz, Kausik Kumar Ray · 2023 · The Lancet Regional Health - Europe
  70. Perspectives on improving blood pressure control to reduce the clinical and economic burden of hypertension
    Giuseppe Mancia, Francesco Paolo Cappuccio, Michel Burnier, António Coca, Alexandre Persu, Claudio Borghi, Reinhold Hugo Kreutz, Bernd Martin Sanner · 2023 · Journal of Internal Medicine
  71. Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial
    Anthony Rodgers, Abdul Salam, Aletta Elisabeth Schutte, William C. Cushman, H Asita de Silva, Gian Luca Di Tanna, Diederick E. Grobbee, Krzysztof Narkiewicz, Dike Bevis Ojji, Neil R Poulter et al. · 2024 · The Lancet
  72. Prevalence and risk factors for hypertensive crisis in a predominantly African American inner-city community
    Frederick Andrew Waldron, Irina Benenson, Shelley A. Jones-Dillon, Shreni N. Zinzuwadia, Adedamola M. Adeboye, Ela Eris, Nkechi E. Mbadugha, Natali Vicente, Alexandra Over · 2019 · Blood Pressure
  73. Long‐Term Exposure to Elevated Systolic Blood Pressure in Predicting Incident Cardiovascular Disease: Evidence From Large‐Scale Routine Electronic Health Records
    José Roberto Ayala Solares, Dexter Canoy, Francesca Elisa Diletta Raimondi, Yajie Zhu, Abdelǎali Hassaïne, Gholamreza Salimi‐Khorshidi, Jenny Tran, Emma Copland, Mariagrazia Zottoli, Ana‐Catarina Pinho‐Gomes et al. · 2019 · Journal of the American Heart Association
  74. Early detection of left atrial dysfunction assessed by CMR feature tracking in hypertensive patients
    Lu Li, Xiuyu Chen, Gang Yin, Weipeng Yan, Chen Cui, Huaibin Cheng, Minjie Lu, Shihua Zhao · 2019 · European Radiology
  75. Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia
    Cunningham, Emma L, Todd, Stephen A, Passmore, Peter, Bullock, Roger, McGuinness, Bernadette · 2021 · Cochrane Database of Systematic Reviews
  76. Administration with Quinoa Protein Reduces the Blood Pressure in Spontaneously Hypertensive Rats and Modifies the Fecal Microbiota
    Huimin Guo, Yuqiong Hao, Xin Min Fan, Aurore Richel, Nadia Everaert, Xiushi Yang, Guixing Ren · 2021 · Nutrients
  77. Estimated pulse wave velocity improves risk stratification for all-cause mortality in patients with COVID-19
    Kimon S. Stamatelopoulos, Georgios A. Georgiopoulos, Kenneth Frank Baker, Giusy Tiseo, Dimitrios Delialis, Charalampos Lazaridis, Greta Barbieri, Stefano Masi, Nikolaos I. Vlachogiannis, Kateryna Sopova et al. · 2021 · Scientific Reports
  78. The role of metabolic syndrome in sudden cardiac death risk: Recent evidence and future directions
    Amedeo Tirandi, Federico Carbone, Fabrizio Montecucco, Luca Liberale · 2021 · European Journal of Clinical Investigation
  79. Hypertension in stroke survivors and associations with national premature stroke mortality: data for 2·5 million participants from multinational screening campaigns
    Queran Lin, Tingxi Ye, Pengpeng Ye, Claudio Borghi, Suzie Cro, Albertino Antonio Moura Damasceno, Nadia A. Khan, Peter M Nilsson, Dorairaj Prabhakaran, Agustín José Ramirez et al. · 2022 · The Lancet Global Health
  80. Seasonal Variation of Home Blood Pressure and Its Association With Target Organ Damage: The J-HOP Study (Japan Morning Surge-Home Blood Pressure)
    Narita, Keisuke, Hoshide, Satoshi, Fujiwara, Takeshi, Kanegae, Hiroshi, Kario, Kazuomi · 2020 · American Journal of Hypertension
  81. The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk
    Nicola Riccardo Pugliese, Alessandro Mengozzi, Agostino Virdis, Edoardo Casiglia, Valérie Tikhonoff, Arrigo F.G. Cicero, Andrea Ungar, Giulia Rivasi, Massimo Salvetti, Carlo Maria Barbagallo et al. · 2021 · Clinical Research in Cardiology
  82. Associations of Systolic Blood Pressure and Diastolic Blood Pressure With the Incidence of Coronary Artery Disease or Cerebrovascular Disease According to Glucose Status
    Mayuko Harada Yamada, Kazuya Fujihara, Satoru Kodama, Takaaki Sato, TAEKO OSAWA, Yuta Yaguchi, Masahiko Yamamoto, Masaru Kitazawa, Yasuhiro Matsubayashi, Takaho Yamada et al. · 2021 · Diabetes Care
  83. Twenty-Four–Hour Central (Aortic) Systolic Blood Pressure: Reference Values and Dipping Patterns in Untreated Individuals
    Thomas Weber, Athanase D. Protogerou, Mohsen Agharazii, Antonis Argyris, Sola Aoun Bahous, Jose R. Banegas, Ronald K. Binder, Jacques Blacher, Andréa Araujo Brandao, Juan J. Cruz et al. · 2021 · Hypertension
  84. Cardiovascular risk assessment tools in Asia
    Yuqing Zhang, Huanhuan Miao, Yook Chin Chia, Peera Buranakitjaroen, Saulat Siddique, Jinho Shin, Yuda Turana, Sungha Park, Kelvin K.F. Tsoi, Chen, Chen Huan et al. · 2022 · Sunway Institutional Repository (Sunway University)
  85. Drivers and scorecards to improve hypertension control in primary care practice: Recommendations from the HEARTS in the Americas Innovation Group
    Jeffrey W. Brettler, Gloria P Giraldo Arcila, Teresa Aumala, Allana Best, Norm R.C. Campbell, Shana Cyr, Ángelo Gamarra, Marc G. Jaffe, Mirna Jimenez De la Rosa, Javier Isaac Maldonado Figueredo et al. · 2022 · The Lancet Regional Health - Americas
  86. Nonalcoholic Fatty Liver Disease: Review of Management for Primary Care Providers
    Rita Basu, Mazen Noureddin, Jeanne M. Clark · 2022 · Mayo Clinic Proceedings
  87. Time-restricted eating with calorie restriction on weight loss and cardiometabolic risk: a systematic review and meta-analysis
    Jing-Chao Sun, Zhen-Tao Tan, Chao-Jie He, Hui-Lin Hu, Chang-Lin Zhai, Gang Qian · 2023 · European Journal of Clinical Nutrition
  88. Empagliflozin Suppresses the Differentiation/Maturation of Human Epicardial Preadipocytes and Improves Paracrine Secretome Profile
    Masayuki Takano, Hidekazu Kondo, Taisuke Harada, Masaki Takahashi, Yumi Ishii, Hirochika Yamasaki, Shan Tong, Kumiko Akiyoshi, Takashi Shuto, Yasushi Teshima et al. · 2023 · JACC Basic to Translational Science
  89. Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program
    Michel Azizi, Andrew S. P. Sharp, Naomi D.L. Fisher, Michael A. Weber, Melvin David Lobo, Joost Daemen, Philipp C. Lurz, Felix Mahfoud, Roland Erich Schmieder, Jan Basile et al. · 2023 · Circulation
  90. Prevalence and Risk Factors for Secondary Hypertension in Young Adults
    Jean-Baptiste de Fréminville, Margherita Gardini, Antoine Cremer, Scarlett Camelli, Stéphanie Baron, Guillaume Bobrie, Philippe Gosse, Romain Boulestreau, Nicole Gebara, Julien Doublet et al. · 2024 · Hypertension
  91. Association between atherogenic index of plasma and new-onset stroke in a population with cardiovascular-kidney-metabolic syndrome stages 0–3: insights from CHARLS
    Yingcheng Liu, Wenlong Li, Hanwen Zhou, Haijiao Zeng, Jiaming Jiang, Qian Wang, Tian Liu, Xinjing Liu, Pinyi Chen, Xiaoni Zhong · 2025 · Cardiovascular Diabetology
  92. Hypertension Management at Older Age: An Update
    Rita Del Pinto, Claudio Ferri · 2018 · High Blood Pressure & Cardiovascular Prevention
  93. The potency of education programs for management of blood pressure through increasing self-efficacy of hypertensive patients: A systematic review and meta-analysis
    Elaheh Foroumandi, Sorayya Kheirouri, Mohammad Alizadeh · 2019 · Patient Education and Counseling
  94. Prevention and treatment of stroke in patients with chronic kidney disease: an overview of evidence and current guidelines
    Dearbhla Kelly, Peter Malcolm Rothwell · 2019 · Kidney International
  95. Isolated Nocturnal Hypertension: What Do We Know and What Can We Do?
    Marijana Vaso Tadic, Cesare Cuspidi, Guido M. Grassi, Giuseppe Mancia · 2020 · Integrated Blood Pressure Control
  96. Camellia oil lowering blood pressure in spontaneously hypertension rats
    Li‐Na Guo, Yiting Guo, Ping Wu, Feng Lai Lu, Junsong Zhu, Haile Ma, Yong Chen, Tao Zhang · 2020 · Journal of Functional Foods
  97. Twenty-Four-Hour Ambulatory Blood Pressure Monitoring
    Camilo Pena-Hernandez, KENNETH M. NUGENT, Meryem Tuncel · 2020 · Journal of Primary Care & Community Health
  98. Pulse Pressure, Prognosis, and Influence of Sacubitril/Valsartan in Heart Failure With Preserved Ejection Fraction
    Kota Suzuki, Brian Lee Claggett, Masatoshi Minamisawa, Kotaro Nochioka, Gary F. Mitchell, Inder S. Anand, Faiez M. Zannad, Sanjiv Jayendra Shah, Martin P. Lefkowitz, Victor Chengwei Shi et al. · 2020 · Hypertension
  99. High prevalence and a long delay in the diagnosis of primary aldosteronism among patients with young‐onset hypertension
    Sarah Alam, Devasenathipathy Kandasamy, Alpesh Goyal, Sreenivas Vishnubhatla, Sandeep Singh, Ganesan Karthikeyan, Rajesh Khadgawat · 2021 · Clinical Endocrinology
  100. Dietary total antioxidant capacity as a preventive factor against depression in climacteric women
    Oliveira, Natiani Gonçalves de, Teixeira, Iranice Taís, Theodoro, Heloísa, Branco, Catia Santos · 2019 · Dementia & Neuropsychologia